These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


107 related items for PubMed ID: 3102386

  • 21. Ocular infections: antibiotics and bacterial adhesion on biomaterials used in ocular surgery.
    Marone P, Perversi L, Monzillo V, Maserati R, Antoniazzi E.
    Ophthalmologica; 1995; 209(6):315-8. PubMed ID: 8751338
    [Abstract] [Full Text] [Related]

  • 22. International experiences with ofloxacin, a new quinolone.
    Mitsuhashi S.
    Infection; 1986; 14 Suppl 4():S223-5. PubMed ID: 3028965
    [Abstract] [Full Text] [Related]

  • 23. Influence of new quinolones on normal immune capabilities.
    Tawfik AF, Shoeb HA, Bishop SJ, al-Shammary FJ, Shibl AM.
    J Chemother; 1990 Oct; 2(5):300-5. PubMed ID: 2090768
    [Abstract] [Full Text] [Related]

  • 24. Comparative study on the macrolides erythromycin and clarithromycin: antibacterial activity and influence on immune responses.
    Roszkowski K, Beuth J, Ko HL, Peters G, Pulverer G.
    Zentralbl Bakteriol; 1990 Sep; 273(4):518-30. PubMed ID: 2147373
    [Abstract] [Full Text] [Related]

  • 25. Comparative activity of ofloxacin and seven other antimicrobials against urea-splitting microorganisms.
    Torres A, Fernández-Roblas R, Méndez B, Soriano F.
    Infection; 1986 Sep; 14 Suppl 4():S233-6. PubMed ID: 3469152
    [Abstract] [Full Text] [Related]

  • 26. [Susceptibilities of bacteria isolated from patients with respiratory infectious diseases to antibiotics (1992)].
    Ikemoto H, Watanabe K, Mori T, Igari J, Oguri T, Kobayashi K, Satou K, Matsumiya H, Saito A, Terai T, Tanno Y, Nishioka K, Arakawa M, Wada K, Okada M, Ozaki K, Aoki N, Kitamura N, Sekine O, Suzuki Y, Tanimoto H, Nakata K, Nakamori Y, Nakatani T, Kusano N.
    Jpn J Antibiot; 1996 Jan; 49(1):34-70. PubMed ID: 8851305
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. New techniques for assessing pathogenicity of quinolone-resistant bacteria.
    Gemmell CG, Felmingham D.
    J Antimicrob Chemother; 1990 Dec; 26 Suppl F():157-63. PubMed ID: 2127271
    [Abstract] [Full Text] [Related]

  • 29. Comparative in vitro activity of three new quinolone antibiotics against recent clinical isolates.
    Forsgren A.
    Scand J Infect Dis; 1985 Dec; 17(1):91-4. PubMed ID: 3158070
    [Abstract] [Full Text] [Related]

  • 30. The in-vitro activities of enoxacin and ofloxacin compared with that of ciprofloxacin.
    King A, Shannon K, Phillips I.
    J Antimicrob Chemother; 1985 May; 15(5):551-8. PubMed ID: 3159712
    [Abstract] [Full Text] [Related]

  • 31. Ofloxacin: in vitro and in vivo activity.
    Guerra L, Caro B, Erani E, Xerri L.
    Chemioterapia; 1987 Feb; 6(1):23-31. PubMed ID: 3470154
    [Abstract] [Full Text] [Related]

  • 32. Methicillin-resistant staphylococci and ofloxacin-resistant bacteria from clinically healthy conjunctivas.
    Watanabe K, Numata-Watanabe K, Hayasaka S.
    Ophthalmic Res; 2001 Feb; 33(3):136-9. PubMed ID: 11340403
    [Abstract] [Full Text] [Related]

  • 33. [The antibacterial activity in vitro of ofloxacin in comparison with other orally administered antimicrobial substances on ampicillin-resistant clinical isolates].
    Seibert G, Klesel N, Limbert M, Schrinner E, Winkler I.
    Arzneimittelforschung; 1984 Feb; 34(11):1552-4. PubMed ID: 6596953
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Influence of pH and human urine on the antibacterial activity of ciprofloxacin, norfloxacin and ofloxacin.
    Zeiler HJ.
    Drugs Exp Clin Res; 1985 Feb; 11(5):335-8. PubMed ID: 2941261
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Comparative in vitro activity of ciprofloxacin, ofloxacin and pefloxacin against resistant clinical isolates.
    Periti P, Mazzei T, Nicoletti P.
    Chemioterapia; 1987 Apr; 6(2):75-8. PubMed ID: 3474081
    [Abstract] [Full Text] [Related]

  • 39. Enoxacin-induced modification of the susceptibility of bacteria to phagocytic killing.
    Pruul H, Kriek G, McDonald PJ.
    J Antimicrob Chemother; 1988 Feb; 21 Suppl B():19-27. PubMed ID: 3129391
    [Abstract] [Full Text] [Related]

  • 40. Mutation rates to 4-quinolone resistance.
    Smith JT.
    Arzneimittelforschung; 1990 Jan; 40(1):65-8. PubMed ID: 2111135
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 6.